ACADIAN ASSET MANAGEMENT LLC - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 18 filers reported holding VASCULAR BIOGENICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q4 2022$33
-100.0%
280,191
-51.0%
0.00%
Q3 2022$88,000
+388.9%
572,211
+4079.5%
0.00%
Q1 2020$18,000
+260.0%
13,691
+237.5%
0.00%
Q2 2019$5,000
-94.4%
4,056
-93.2%
0.00%
Q1 2019$90,000
+500.0%
59,427
+272.3%
0.00%
Q4 2018$15,000
-91.0%
15,961
-78.0%
0.00%
-100.0%
Q1 2018$167,00072,6350.00%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 152,764$365,0000.50%
Ikarian Capital, LLC 800,811$1,915,0000.16%
DAFNA Capital Management LLC 306,980$734,0000.15%
PVG ASSET MANAGEMENT CORP 12,155$29,050,0000.09%
Phoenix Holdings Ltd. 1,060,300$2,534,0000.05%
Virtu Financial LLC 39,618$95,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 89,689$214,0000.01%
HBK Sorce Advisory LLC 22,000$53,0000.00%
MORGAN STANLEY 693,420$1,658,0000.00%
Bank of New York Mellon Corp 25,000$60,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders